NovoCure (NVCR) Research & Development (2014 - 2026)
NovoCure recorded quarterly Research & Development of $58.3 million in Q1 2026, down 4.22% quarter-over-quarter from $60.9 million in Q4 2025, and up 8.48% year-over-year from $53.8 million in Q1 2025.
NovoCure's Research & Development history runs 13 years deep, the most recent figure standing at $58.3 million for Q1 2026.
- In Q1 2026, Research & Development rose 8.48% year-over-year to $58.3 million; the TTM figure through Mar 2026 stood at $229.1 million (up 8.16% YoY), while the FY2025 annual figure was $224.5 million, up 7.11% from the prior year.
- Research & Development came in at $58.3 million for Q1 2026 at NovoCure, down from $60.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $60.9 million in Q4 2025 to a low of $42.2 million in Q1 2022.
- A 5-year average of $54.2 million and a median of $54.3 million in 2023 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 41.36% in 2023 and decreased 13.58% in 2024, its largest moves.
- NovoCure's Research & Development stood at $54.8 million in 2022, then declined by 0.93% to $54.3 million in 2023, then decreased by 5.7% to $51.2 million in 2024, then rose by 18.93% to $60.9 million in 2025, then dropped by 4.22% to $58.3 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $58.3 million, $60.9 million, and $54.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 58.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.34 Mn |
| Dec 31, 2025 | 60.91 Mn |
| Sep 30, 2025 | 54.03 Mn |
| Jun 30, 2025 | 55.83 Mn |
| Mar 31, 2025 | 53.78 Mn |
| Dec 31, 2024 | 51.21 Mn |
| Sep 30, 2024 | 51.88 Mn |
| Jun 30, 2024 | 54.96 Mn |
| Mar 31, 2024 | 51.60 Mn |
| Dec 31, 2023 | 54.31 Mn |
| Sep 30, 2023 | 53.62 Mn |
| Jun 30, 2023 | 55.43 Mn |
| Mar 31, 2023 | 59.70 Mn |
| Dec 31, 2022 | 54.82 Mn |
| Sep 30, 2022 | 51.96 Mn |
| Jun 30, 2022 | 57.08 Mn |
| Mar 31, 2022 | 42.23 Mn |
| Dec 31, 2021 | 56.93 Mn |
| Sep 30, 2021 | 48.14 Mn |
| Jun 30, 2021 | 50.32 Mn |
| Mar 31, 2021 | 45.92 Mn |
| Dec 31, 2020 | 44.00 Mn |
| Sep 30, 2020 | 32.82 Mn |
| Jun 30, 2020 | 29.92 Mn |
| Mar 31, 2020 | 25.27 Mn |
| Dec 31, 2019 | 23.74 Mn |
| Sep 30, 2019 | 18.77 Mn |
| Jun 30, 2019 | 19.45 Mn |
| Mar 31, 2019 | 17.04 Mn |
| Dec 31, 2018 | 15.03 Mn |
| Sep 30, 2018 | 13.07 Mn |
| Jun 30, 2018 | 11.36 Mn |
| Mar 31, 2018 | 11.10 Mn |
| Dec 31, 2017 | 10.05 Mn |
| Sep 30, 2017 | 9.27 Mn |
| Jun 30, 2017 | 9.37 Mn |
| Mar 31, 2017 | 9.41 Mn |
| Dec 31, 2016 | 8.47 Mn |
| Sep 30, 2016 | 10.23 Mn |
| Jun 30, 2016 | 11.32 Mn |
| Mar 31, 2016 | 11.45 Mn |
| Dec 31, 2015 | 10.85 Mn |
| Sep 30, 2015 | 10.21 Mn |
| Jun 30, 2015 | 12.77 Mn |
| Mar 31, 2015 | 9.93 Mn |
| Dec 31, 2014 | 11.19 Mn |
| Sep 30, 2014 | 9.28 Mn |